# Enzyme Inhibition Kinetics and Molecular Transporters

> Enzyme Inhibition Kinetics and Molecular Transporters establishes the physical-chemical laws, mathematical models, and structural biology governing how inhibitors suppress catalytic enzymes and how…

Canonical: https://wiki.soapbox.community/wiki/Enzyme_Inhibition_Kinetics_and_Molecular_Transporters
Section: Substances and pharmacology, Organic chemistry and synthesis
Last updated: 2026-09-28
Publisher: Library of Ashurbanipal (Van Kush Family Research Institute), https://wiki.soapbox.community

**Enzyme Inhibition Kinetics and Molecular Transporters** establishes the physical-chemical laws, mathematical models, and structural biology governing how inhibitors suppress catalytic enzymes and how transporter proteins govern neurotransmitter clearance. From Michaelis-Menten dynamics to the serine hydrolase superfamily and solute carrier (SLC) transporters, this article provides the foundational framework connecting cannabinoid enzymes, monoamine oxidases, and cholinesterases.

## Mathematical models of enzyme inhibition

Enzyme velocity ($V$) as a function of substrate concentration ($[S]$) follows the classical Michaelis-Menten equation:
: V = (Vmax · [S]) / (Km + [S])
where $V_{max}$ is the maximum catalytic rate at substrate saturation, and $K_m$ (the Michaelis constant) represents the substrate concentration at which velocity is half-maximal ($V_{max}/2$), inversely reflecting substrate affinity.

Inhibitors perturb this relationship through distinct kinetic modes, diagnosable via double-reciprocal Lineweaver-Burk plots ($1/V$ versus $1/[S]$):

{| class="wikitable"
! Inhibition mode !! Binding target !! Effect on Vmax !! Effect on Km !! Lineweaver-Burk intersection !! Biological example
|-
| **Competitive** || Free enzyme active site ($E$) || **Unchanged** || **Increased** (Lower affinity) || Intersects at y-axis ($1/V_{max}$) || Galantamine at AChE; Macamides at FAAH
|-
| **Non-Competitive** || Allosteric site on both $E$ and $ES$ equally || **Decreased** || **Unchanged** || Intersects at x-axis ($-1/K_m$) || Heavy metals; certain flavonoid allosteric modulators
|-
| **Uncompetitive** || Only the enzyme-substrate complex ($ES$) || **Decreased** || **Decreased** || Parallel lines (slope unchanged) || Lithium at inositol monophosphatase
|-
| **Mixed** || Allosteric site; unequal affinity for $E$ vs $ES$ || **Decreased** || **Increased or Decreased** || Intersects to the left of y-axis || Pristimerin at MAGL
|-
| **Irreversible (Suicide)** || Active catalytic residues (Covalent) || **Permanently lowered** || Apparent shift || Progressive time-dependent loss || Organophosphates at AChE; URB597 at FAAH
|}

### 1. Competitive inhibition dynamics

Because competitive inhibitors bind reversibly to the exact catalytic pocket used by the substrate, excess substrate can completely displace the inhibitor:
- At infinite substrate concentration, maximal velocity ($V_{max}$) is fully achieved.
- This property underpins why Reversible Inhibitors of MAO-A (RIMAs) avoid the tyramine "cheese crisis"—dietary tyramine surges displace the inhibitor and preserve clearance.

### 2. Irreversible and mechanism-based suicide inhibition

- Suicide inhibitors are initially recognized as substrates by the enzyme.
- The catalytic machinery converts the inhibitor into a chemically reactive species that forms a permanent covalent bond with active site amino acids, destroying the enzyme.
- Restoring catalytic activity requires **de novo protein synthesis**, explaining why the physiological effects of compounds like irreversible MAOIs (phenelzine) or mechanism-based CYP3A4 inhibitors (grapefruit furanocoumarins) outlast the presence of the drug in plasma by days or weeks.

## The Serine Hydrolase Superfamily

A remarkable unity across pharmacology is that **FAAH, MAGL, Acetylcholinesterase (AChE), and Carboxylesterases** all belong to the broader **serine hydrolase superfamily**. They share a common catalytic mechanism:

[ Free Enzyme: Enz-CH2-OH (Serine) ] + [ Substrate: R-CO-X ]
                           │
                           ▼  Nucleophilic Attack by Catalytic Serine
[ Tetrahedral Intermediate 1 ]
                           │
                           ▼  Expulsion of Leaving Group (X-H)
[ Covalent Acyl-Enzyme Intermediate: Enz-CH2-O-CO-R ]
                           │
                           ▼  Nucleophilic Attack by Water (H2O)
[ Tetrahedral Intermediate 2 ]
                           │
                           ▼  Release of Carboxylic Acid (R-COOH)
[ Regenerated Free Enzyme: Enz-CH2-OH ]

### 1. The universal catalytic serine nucleophile

- Whether organized as a canonical Ser-His-Asp triad (AChE, MAGL) or an amidase Ser-Ser-Lys triad (FAAH), the catalytic core relies on an activated serine hydroxyl ($-\text{CH}_2\text{-OH}$) acting as a powerful nucleophile.
- The serine attacks the carbonyl carbon of esters, amides, or thioesters, forming a transient covalent **acyl-enzyme intermediate**.
- Water attacks the intermediate (deacylation), releasing the reaction product and regenerating the active enzyme.

### 2. Cross-reactivity and target vulnerability

- Because these enzymes share this identical catalytic nucleophile, electrophilic chemical classes—specifically **carbamates**, **ureas**, and **organophosphates**—can cross-react across multiple family members.
- If a synthetic drug molecule is designed with excessive electrophilic reactivity, it will non-selectively carbamylate or phosphorylate off-target serine hydrolases throughout the brain. This exact mechanism produced the 2016 BIA 10-2474 trial tragedy, where an unselective candidate inhibited FAAH alongside ABHD6, ABHD11, and neuropathy target esterase (PNPLA6), destroying neuronal lipid homeostasis.

## Molecular reuptake transporters

Where enzymes clear neurotransmitters by chemical destruction, **molecular transporters** clear neurotransmitters by physically pumping them across cellular membranes against steep concentration gradients:

                         [ MOLECULAR TRANSPORTERS ]
                                     │
           ┌─────────────────────────┼─────────────────────────┐
           ▼                         ▼                         ▼
[ SLC6 Plasma Transporters ]  [ SLC18 Vesicular (VMAT2) ]  [ Intracellular Chaperones ]
 • SERT (Serotonin / SSRIs)    • Pumps monoamines into      • FABP5 / FABP7 (Anandamide)
 • DAT (Dopamine / Stimulants)   presynaptic vesicles       • Chaperones lipids through
 • NET (Norepinephrine)        • Powered by H⁺-ATPase         cytosol to FAAH / MAGL
 • GAT1 (GABA / Anticonvulsants) • Reserpine target

### 1. The Solute Carrier 6 (SLC6) superfamily

- The plasma membrane monoamine transporters—**SERT (SLC6A4)**, **DAT (SLC6A3)**, and **NET (SLC6A2)**—are $Na^+/Cl^-$-coupled symporters.
- They utilize the steep electrochemical gradient generated by the $Na^+/K^+$-ATPase pump (two sodium ions and one chloride ion transported inward per neurotransmitter molecule) to drive high-affinity reuptake from the synaptic cleft into the presynaptic cytoplasm.
- **Inhibition:** Selective Serotonin Reuptake Inhibitors (SSRIs) like fluoxetine or sertraline competitively block the substrate translocation pathway of SERT, trapping 5-HT in the cleft. Cocaine and methylphenidate block DAT, elevating synaptic dopamine.
- **Reversal:** Amphetamines act as substrate-mimics, entering the terminal and reversing the direction of transporter flux, causing DAT and SERT to pump monoamines outward into the synapse independently of action potentials.

### 2. Vesicular Monoamine Transporter 2 (VMAT2 / SLC18A2)

- Once monoamines are returned to the presynaptic cytoplasm by SLC6 transporters, they face immediate oxidative deamination by mitochondrial monoamine oxidase (MAO).
- To prevent destruction and permit future release, **VMAT2** packages cytoplasmic monoamines into acidic storage vesicles, utilizing a proton electrochemical gradient generated by a vacuolar $H^+$-ATPase ($2\text{ }H^+$ pumped out per monoamine pumped in).
- The classical antihypertensive reserpine irreversibly inhibits VMAT2, causing total monoamine depletion and severe clinical depression.

### 3. Endocannabinoid transport and FABP chaperones

- Because endocannabinoids are lipophilic lipids, they cannot diffuse freely through the aqueous cytoplasm to reach membrane-bound intracellular degrading enzymes (FAAH and MAGL).
- Intracellular transport is mediated by **Fatty Acid Binding Proteins**—specifically **FABP5** and **FABP7**—alongside heat shock protein 70 (HSP70).
- Inhibiting FABPs prevents anandamide from reaching intracellular FAAH, functioning as a non-enzymatic method to elevate synaptic endocannabinoid signaling.

See also: The Expanded Endocannabinoid System and FAAH Science · Cholinergic Neurotransmission and Cholinesterase Inhibition · Monoamine Oxidase Inhibitors and Neurotransmitter Systems · Cytochrome P450 System Inhibition and Induction · Stack Substances